Prenatal Lymphedema: A Genotype-Phenotype Analysis

Michal Ad1, Arin K Greene1

  • 1Department of Plastic and Oral Surgery, Lymphedema Program, Boston Children's Hospital, Harvard Medical School, Boston, MA.

Journal of Vascular Anomalies
|June 12, 2026
PubMed

Insights

Prenatal lymphedema, often linked to VEGFC mutations, may resolve after birth. This condition, typically affecting lower limbs, can present before birth and may not persist postnatally.

Area of Science:

  • Genetics
  • Pediatrics
  • Medical Imaging

Background:

  • Primary lymphedema is a progressive, incurable condition affecting lower extremities, often presenting in infancy or adolescence.
  • Genetic mutations in approximately 30 genes are associated with primary lymphedema.
  • Prenatal diagnosis of lymphedema is rare, identified in 1% of cases in the study database.

Purpose of the Study:

  • To investigate the characteristics and outcomes of primary lymphedema diagnosed prenatally.
  • To explore the association between prenatal lymphedema and specific genetic mutations, particularly in VEGFC.
  • To determine if prenatal lymphedema resolves postnatally and assess lymphatic function.

Main Methods:

  • Retrospective analysis of a database of primary lymphedema patients.
  • Identification of cases diagnosed via prenatal imaging.
  • Review of postnatal clinical presentation, genetic testing (VEGFC mutations), and lymphatic function assessment (lymphoscintigraphy).

Main Results:

  • Four out of 364 (1%) patients with primary lymphedema were diagnosed prenatally.
  • Of the four prenatally diagnosed cases, three did not exhibit lymphedema after birth.
  • Two of the resolved cases had a VEGFC mutation, and two showed normal lymphatic function postnatally.

Conclusions:

  • Prenatal lymphedema, particularly when associated with VEGFC mutations, can be transient and may resolve postnatally.
  • Prenatal imaging can identify lymphedema, but postnatal assessment is crucial for determining its persistence and lymphatic function.
  • The findings suggest a potential subset of lymphedema cases with a favorable prognosis, linked to specific genetic factors and resolving lymphatic abnormalities.

Related Concept Videos

Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Pedigree Analysis01:35

Pedigree Analysis

Overview
Punnett Squares01:00

Punnett Squares

Overview
Development of the Lymphatic System01:15

Development of the Lymphatic System

The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
Genetic Lingo01:11

Genetic Lingo

Overview
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...